文献速递脊柱关节炎

德国普通人群骶髂关节骨髓水肿的患病率及决定因素:一项基于人群的横断面研究

Prevalence and determinants of sacroiliac joint bone marrow oedema in the general population in Germany: a population-based cross-sectional study.
PubMed 文献 · Lancet Rheumatol · 2026-05-06

该研究基于德国国家队列2014至2016年全身MRI数据,分析20-69岁成年人骶髂关节骨髓水肿的患病率及决定因素。

要点

  • 女性患病率高于男性,妊娠史、BMI≥25 kg/m2和职业性体力工作与骨髓水肿相关。
  • 骨髓水肿常由非炎症性原因引起,解读MRI需结合临床背景以避免过度诊断。

核心结论

  • 骶髂关节骨髓水肿影响近三分之一成年人,与妊娠、超重和职业性体力应激相关而非炎症性疾病。
  • 该患病率超过自报中轴型脊柱关节炎50倍,为MRI表现提供人群参考数据。
  • 骨髓水肿作为ASAS标准中骶髂关节炎的关键影像标志,常由非炎症性原因引起。

研究设计与样本

  • 三位设盲专家独立评估随机选取的参与者,其余参与者使用经验证的深度学习算法自动分割和量化骨髓水肿体积。
  • 采用多变量logistic回归分析骨髓水肿与人口学、生活方式和生殖因素的关联,并进行性别分层分析。

关键数值与推荐

  • 骨髓水肿定义为主要结局,通过专家判读或深度学习算法从脂肪抑制质子密度序列中自动分割和量化。

临床怎么用

  • 解读骶髂关节MRI骨髓水肿时需结合临床背景,考虑妊娠、超重和职业性体力负荷等非炎症性因素。
  • 人群参考数据可用于支持开发更特异的影像阈值,以减少误诊和不适当治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: MRI-detected bone marrow oedema in sacroiliac joints is central to diagnosing axial spondyloarthritis, influencing treatment decisions including anti-inflammatory therapy initiation. However, the prevalence of bone marrow oedema in the general population remains unknown, restricting interpretation of MRI findings and potentially leading to overdiagnosis when imaging findings are considered without clinical context. We aimed to establish the prevalence and determinants of sacroiliac bone marrow oedema in the general adult population. METHODS: In this national, population-based, cross-sectional study, we analysed adults aged 20-69 years from the German National Cohort who underwent whole-body MRI between May 1, 2014, and Dec 31, 2016. Three masked experts independently assessed randomly selected participants for sacroiliac bone marrow oedema. The remaining participants were evaluated using a validated deep-learning algorithm that automatically segments and quantifies bone marrow oedema volume from fat-suppressed proton density sequences. We examined associations between the presence of bone marrow oedema (primary outcome) and demographic, lifestyle, and reproductive factors using multivariable logistic regression with sex-stratified analyses to identify differential patterns. There was no patient or public involvement in this study. FINDINGS: Of 11 163 participants (median age 53·0 years [IQR 45·0-61·0], 5432 [48·7%] women and 5731 [51·3%] men), sacroiliac bone marrow oedema was detected in 288 (28·9% [95% CI 26·2-31·9]) of 998 participants analysed by expert readers and 3131 (30·8% [29·9-31·7]) of 10 165 participants analysed by the deep-learning algorithm, approximately 50 times higher than the 0·6% prevalence of self-reported axial spondyloarthritis diagnosis. Bone marrow oedema prevalence was higher in women (33·9% [95% CI 32·6-35·3]) than in men (27·8% [26·6-29·1]; adjusted odds ratio [OR] 1·33 [95% CI 1·23-1·45]). In women, pregnancy history was associated with bone marrow oedema compared with nulliparous women (OR 1·43 [95% CI 1·21-1·71]). In men, age (OR 1·28 per decade [95% CI 1·21-1·35]) and intensive recreational physical activity (1·24 [1·08-1·42]) showed independent associations, whereas age effects were minimal in women (1·16 per decade [1·11-1·23]). Of modifiable risk factors, BMI of 25 kg/m2 and above showed the highest OR (1·62 [1·47-1·79]). Physically demanding occupational work was associated with bone marrow oedema overall (OR 1·25 [95% CI 1·14-1·36]). INTERPRETATION: Sacroiliac bone marrow oedema affects nearly one-third of adults, showing associations with pregnancy, overweight, and occupational physical stress rather than inflammatory disease. This prevalence exceeds self-reported axial spondyloarthritis by 50 times, providing essential population reference data for contextualising MRI findings. These findings show that bone marrow oedema, the key imaging marker for sacroiliitis in Assessment of Spondyloarthritis International Society criteria, commonly occurs from non-inflammatory causes. These population-based data can inform diagnostic interpretation and support development of more specific imaging thresholds to reduce misdiagnosis and inappropriate treatments. FUNDING: Max Kade Foundation and Novartis.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Bressem K, Torgutalp M, Diekhoff T, et al. Prevalence and determinants of sacroiliac joint bone marrow oedema in the general population in Germany: a population-based cross-sectional study. Lancet Rheumatol. 2026. PMID: 42105782. doi:10.1016/S2665-9913(26)00071-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。